Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular Tranexamic Acid in ACL Reconstruction
NCT04042688Phase 4Unknown
- Sponsor
- Korea University Guro Hospital
- Start
- Jul 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of tranexamic acid in hemarthrosis and postoperative pain (2 arms), sponsored by Korea University Guro Hospital. Primary endpoint: Blood loss calculated based on hemoglobin balance at 2 days. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
hemarthrosispostoperative pain
Beyond the preview
Go deeper on NCT04042688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04042688.